This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

About the NKI

The Netherlands Cancer Institute was established on October 10, 1913. The founders, Rotgans, professor of Surgery, De Bussy, publisher, and De Vries, professor of Pathology, wanted to create a cancer institute 'where patients suffering from malignant growths could be treated adequately and where cancer and related diseases could be studied'. They bought a house on one of the canals in Amsterdam and named it the 'Antoni van Leeuwenhoek Huis', after the famous Dutch microscopist. The clinic had room for 17 patients, while the laboratory could accommodate 8 to 10 scientists.

Nowadays, The Netherlands Cancer Institute accommodates approximately 650 scientists and scientific support personnel. The Antoni van Leeuwenhoek Hospital has 185 medical specialists, 180 beds, an out-patients clinic with around 106,000 visits, 12 operating theaters and 11 irradiotion units for radiotherapy. It is the only dedicated cancer center in The Netherlands and maintains an important role as a national and international center of scientific and clinical expertise, development and training.


  • 09Aug 2018

    Tumor organoids form 'training school for T cells

    Researchers from the NKI and others have shown in Cell (9 August 2018) that it is possible to obtain T cells from the bloodstream of a cancer patient and expand them in a dish together with a tumor organoid from the same patient. The immune cells develop the ability to kill the tumor cells and to reduce organoid size, while leaving healthy control tissue of the same patient untouched. Cell, 9 August 2018.

    Read More
  • 31Jul 2018

    Flexible lymph node detector successful in prostate cancer patients

    Researchers at Leiden University Medical Centre (LUMC),the commercial enterprise Eurorad and the Antoni van Leeuwenhoek hospital have something to celebrate. The flexible DROP-IN gamma probe that they have developed to track down radioactive lymph nodes has been used safely and successfully in prostate cancer patients. The researchers are reporting their findings in the European Journal of Nuclear Medicine and Molecular Imaging.

    Read More
  • 18Jul 2018

    Clinicians should reduce CT use in children

    Radiation from CT head scans in children increases brain tumor risk, a large study among almost 170,000 children in Dutch hospitals shows. The results are published in the scientific journal JNCI on July 18th. "Doctors should use less CT scans in children whenever possible", says researcher Michael Hauptmann of the Netherlands Cancer Institute.

    Read More
  • 17Jul 2018

    Researchers Ineke Brouwer and Julia Houthuijzen receive Veni Grant

    Postdocs Julia Houthuijzen (group of Jos Jonkers) and Ineke Brouwer (group of Tineke Lenstra) have both been awarded a Veni Grant by the Netherlands Organisation for Scientific Research (NWO). A Veni grant (worth up to 250,000 euros) enables laureates to further elaborate their own research ideas during a period of three years.

    Read More

Board of Directors

Overview boards and commissions


Internal procedures

The NKI has adopted several regulations and procedures which help us organize our research along national and international standards. The most important regulations and procedures can be found here.

Read more


Technology Transfer Office

The NKI has a mission to beat cancer and performs world-beating research to increase our understanding of this disease. The knowledge that is gained in this way sometimes opens avenues for development of e.g. novel treatments or new diagnostic tests. To achieve its mission, NKI actively collaborates with private companies that have the knowledge and the means to develop products based on research results obtained at our institution.

Go to the site of the Technology Transfer Office

Scientific Annual Reports (SAR)



Group Leaders51
PhD Students187


  • Silhoutten



  • Silhoutten



  • Horloge



  • Silhoutten



  • Bed



Key Figures Research

Publications in 2016 805
Total impact of publications in 2014 3935
Avarage impact of publications 2014 6.8

Key Figures Research

Number of divisions 15
Number of Reseach groups 51
Share this page